Document text
Principal Investigator: Paolo Cravedi
Organization: PALO ALTO VETERANS INSTIT FOR RESEARCH
Fiscal Year: 2023
Award: $255,459
Funding agency: National Institute of Allergy and Infectious Diseases
PROJECT SUMMARY / ABSTRACT
Solid organ transplant recipients have increased morbidity and mortality in response to infection with SARS-
CoV-2, the virus responsible for COVID19. While the general population has greatly benefited from the rapid
development of several vaccines that are protective against the development of severe infection, the transplant
recipient population has sub-optimal responses to similar vaccination regimens. Herein, we build on our
published and preliminary data on the cellular and serological responses to SARS-CoV-2 mRNA vaccination in
both liver and kidney transplant recipients. Liver transplant recipients are significantly more likely to respond to
a two-dose regimen with both viral specific T cells and seroconversion when compared with kidney transplant
recipients. Interestingly, although both seroconversion efficiency and T cell activation are affected by the levels
of immunosuppression, the organ transplanted (liver versus kidney) has an independent effect on the humoral
and cellular responses. However, an in depth, mechanistic evaluation of these adaptive immune responses is
lacking. We hypothesize that there are intrinsic differences in immune function, irrespective of the degree of
immunosuppression, between liver and kidney transplant recipients. This proposal builds on an already
productive collaboration between the laboratories of Jonathan Maltzman and Paolo Cravedi. The overall goal
of this work is to use cryopreserved samples to mechanistically understand the features that
characterize effective immune response to SARS-CoV-2 vaccination in kidney transplant recipients. To
address this goal, we propose the following specific aims: Aim 1: Assess the differences in T cell phenotype
and function between solid organ transplant (SOT) recipients that are SARS-CoV-2 vaccine responders
versus non-responders; Aim 2: Determine differences in innate and adaptive immune cell populations
between vaccine responders versus non-responders by measuring chromatin accessibility and gene
expression. This project builds upon the productive collaboration between the Maltzman and Cravedi
laboratories and leverages their expertise. Success of this high-risk proposal has the potential to
comprehensively delineate the immune responses in both kidney and liver transplant recipients upon SARS-
CoV-2 vaccination, a point of critical importance to define biomarkers of response and envision strategies to
improve response (high reward).
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV S protein><2019-nCoV spike glycoprotein><2019-nCoV spike protein><2019-nCoV vaccine><ATAC sequencing><ATAC-seq><ATACseq><Address><Affect><Antibody Response><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><COVID><COVID-19><COVID-19 S protein><COVID-19 spike glycoprotein><COVID-19 spike protein><COVID-19 vaccination><COVID-19 vaccine><COVID-19 virus><COVID19><COVID19 S protein><COVID19 spike glycoprotein><COVID19 spike protein><COVID19 vaccination><COVID19 vaccine><COVID19 virus><CV-19><CV19><Cell Body><Cells><Cellular Immune Function><Chromatin><CoV disease><CoV-2><CoV2><Collaborations><Cryofixation><Cryopreservation><Data><Development><Dose><Epigenetic><Epigenetic Change><Epigenetic Mechanism><Epigenetic Process><Evaluation><Gene Expression><Gene Transcription><General Population><General Public><Genetic Transcription><Goals><Grafting Procedure><Hepatic Transplantation><History><Human><Immune><Immune response><Immunes><Immunological response><Immunosuppression><Immunosuppression Effect><Immunosuppressive Effect><Individual><Infection><Innate Immune Response><Kidney><Kidney Grafting><Kidney Transplantation><Kidney Transplants><Kidney Urinary System><Laboratories><Link><Liver><Liver Grafting><Liver Transplant><Measures><Modern Man><Molecular><Morbidity><Morbidity - disease rate><Organ><Organ Transplantation><Organ Transplants><Outcome><PBMC><Patients><Peripheral Blood Mononuclear Cell><Phenotype><Population><Productivity><Publishing><RNA Expression><RNA immunization><RNA vaccination><RNA vaccine><RNA-based vaccine><Recording of previous events><Regimen><Renal Grafting><Renal Transplantation><Renal Transplants><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 S protein><SARS-CoV-2 spike glycoprotein><SARS-CoV-2 spike protein><SARS-CoV-2 vaccination><SARS-CoV-2 vaccine><SARS-CoV2><SARS-CoV2 S protein><SARS-CoV2 spike glycoprotein><SARS-CoV2 spike protein><SARS-CoV2 vaccine><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 vaccine><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Serology><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 S protein><Severe acute respiratory syndrome coronavirus 2 spike glycoprotein><Severe acute respiratory syndrome coronavirus 2 spike protein><Severe acute respiratory syndrome coronavirus 2 vaccination><Severe acute respiratory syndrome coronavirus 2 vaccine><Severe acute respiratory syndrome related corona virus 2><Solid><T cell clonality><T cell response><T-Cell Activation><T-Cells><T-Lymphocyte><T-cell receptor clonality><TCR clonality><Technology><Testing><Transcription><Transplant Recipients><Vaccination><Vaccines><Viral><Virus><Work><Wuhan coronavirus><activate T cells><adaptive immune response><after COVID-19 infection><after SARS-CoV-2 infection><after SARS-CoV2 infection><after infection by SARS-CoV-2><after severe acute respiratory distress syndrome CoV-2 infection><booster dose><booster shot><booster vaccine><cohort><cold preservation><cold storage><corona virus disease><corona virus disease 2019><corona virus disease 2019 vaccine><coronavirus disease><coronavirus disease 2019><coronavirus disease 2019 S protein><coronavirus disease 2019 spike glycoprotein><coronavirus disease 2019 spike protein><coronavirus disease 2019 vaccination><coronavirus disease 2019 vaccine><coronavirus disease 2019 virus><coronavirus disease-19><coronavirus disease-19 vaccine><coronavirus disease-19 virus><coronavirus infectious disease-19><developmental><epigenetically><experiment><experimental research><experimental study><experiments><following COVID-19 infection><following SARS-CoV-2 infection><following SARS-CoV2 infection><following infection by SARS-CoV-2><following severe acute respiratory distress syndrome CoV-2 infection><hCoV19><hepatic body system><hepatic organ system><high reward><high risk><histories><host response><immune function><immune suppression><immune suppressive activity><immune suppressive function><immune system response><immunoresponse><immunosuppressive activity><immunosuppressive function><immunosuppressive response><improved><kidney tx><liver transplantation><mRNA immunization><mRNA vaccination><mRNA vaccine><mRNA-based vaccine><mortality><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><nCoV2><organ allograft><organ graft><organ transplant recipient><organ xenograft><post SARS-CoV-2 infection><previous COVID-19 infection><previous SARS-CoV-2 infection><previous SARS-CoV2 infection><previous severe acute respiratory distress syndrome CoV-2 infection><prior COVID-19 infection><prior SARS-CoV-2 infection><prior SARS-CoV2 infection><prior severe acute respiratory distress syndrome CoV-2 infection><renal><responders and non-responders><responders from non-responders><responders or non-responders><responders versus non-responders><responders vs non-responders><response><response biomarker><response markers><sNuc-Seq><seroconversion><single nucleus RNA-sequencing><single-nucleus RNA-seq><snRNA-seq><success><thymus derived lymphocyte><transplant patient><vaccinate against COVID-19><vaccinate against COVID19><vaccinate against SARS-CoV-2><vaccinate against coronavirus disease 2019><vaccinate against severe acute respiratory syndrome coronavirus 2><vaccination against COVID-19><vaccination against COVID19><vaccination against SARS-CoV-2><vaccination against Severe acute respiratory syndrome coronavirus 2><vaccination against coronavirus disease 2019><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine for novel coronavirus>